SignatureFD’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.13K Hold
1,076
﹤0.01% 2803
2026
Q1
$4.16K Hold
1,076
﹤0.01% 2838
2025
Q4
$4.5K Sell
1,076
-76
-7% -$294 ﹤0.01% 2727
2025
Q3
$3.79K Buy
1,152
+475
+70% +$1.34K ﹤0.01% 2769
2025
Q2
$961 Buy
+677
New +$962 ﹤0.01% 3031
2023
Q4
Sell
-11,257
Closed -$16K 3234
2023
Q3
$16K Buy
+11,257
New +$16K ﹤0.01% 1968
2022
Q4
Sell
-545
Closed -$1K 3387
2022
Q3
$1K Buy
+545
New +$1.15K ﹤0.01% 3006
2022
Q1
Sell
-146
Closed -$1K 3280
2021
Q4
$1K Buy
+146
New +$628 ﹤0.01% 2974
2021
Q1
Sell
-400
Closed -$4K 2807
2020
Q4
$4K Buy
+400
New +$2.59K ﹤0.01% 2047
2020
Q2
Sell
-108
Closed 2624
2020
Q1
$0 Buy
+108
New +$466 ﹤0.01% 2412
2018
Q2
Sell
-57
Closed -$1K 1960
2018
Q1
$1K Buy
+57
New +$815 ﹤0.01% 1675

Other funds holding PGEN

SignatureFD's PGEN Position: Q2 2026 in Review

SignatureFD held its Precigen (PGEN) position steady in Q2 2026 at 1,076 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2803.

SignatureFD first reported a position in PGEN in Q1 2018 and has held it in 11 quarters since. The position peaked at $16K in Q3 2023. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • SignatureFD held 1,076 shares of Precigen worth $6.13K as of Q2 2026.
  • SignatureFD left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2803 holding.
  • SignatureFD first reported a position in Precigen in Q1 2018 and has held it in 11 quarters since.
  • SignatureFD's Precigen position peaked at $16K in Q3 2023.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.